Range Cancer Therapeutics ETF (CNCR) Dividend Yield, Date & History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CNCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share DividendStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media Dividend SummaryDividend Yield1.88%Annual Dividend$0.29Recent Dividend Payment Dec. 31 Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Email Address Skip Charts & View Dividend HistoryCNCR Dividend PaymentsOpen Range Cancer Therapeutics ETF in Dividend Calculator →CNCR Dividend Yield Over Time Open Range Cancer Therapeutics ETF in Dividend Yield Calculator → Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Range Cancer Therapeutics ETF vs. The CompetitionTypeRange Cancer Therapeutics ETF CompaniesNASDAQ CompaniesAnnual Dividend$0.29$1.32$1.21Dividend Yield1.88%1,529.05%395.97%Annualized 3-Year Dividend Growth0.00%3,361.00%1,380.43% Range Cancer Therapeutics ETF Dividend History by QuarterAnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date12/28/2021Annual$1.85307.75%12/29/202112/30/202112/31/202112/29/2020Annual$0.28800.89%12/30/202012/31/20201/4/202112/28/2017annual$0.35021.47%12/28/201712/29/20171/2/2018(Data available from 1/1/2013 forward) Range Cancer Therapeutics ETF Dividend - Frequently Asked Questions What is Range Cancer Therapeutics ETF's dividend yield? The current dividend yield for Range Cancer Therapeutics ETF is 1.88%. Learn more on CNCR's dividend yield history. How much is Range Cancer Therapeutics ETF's annual dividend? The annual dividend for CNCR shares is $0.29. Learn more on CNCR's annual dividend history. How often does Range Cancer Therapeutics ETF pay dividends? Range Cancer Therapeutics ETF pays annual dividends to shareholders. When was Range Cancer Therapeutics ETF's most recent dividend payment? Range Cancer Therapeutics ETF's most recent annual dividend payment of $1.8530 per share was made to shareholders on Friday, December 31, 2021. When was Range Cancer Therapeutics ETF's most recent ex-dividend date? Range Cancer Therapeutics ETF's most recent ex-dividend date was Wednesday, December 29, 2021. When did Range Cancer Therapeutics ETF last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $1.5650 on Tuesday, December 28, 2021. More Dividend Resources from MarketBeat Related Companies: FTXH Dividend Yield MEDX Dividend Yield JDOC Dividend Yield IBBQ Dividend Yield BIS Dividend Yield BIB Dividend Yield PSCH Dividend Yield BBH Dividend Yield PPH Dividend Yield IBB Dividend Yield Dividend Tools: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator (Web) Dividend Calculator (Excel) Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Stock Lists: Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles: Alphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead3 Small Dividend Paying Banks Insiders are BuyingProfit pillars: 5 Dividend aristocrats for reliable incomeHigher VIX just made Realty Income’s 6% dividend better2 more high-quality dividend growers to buy on the dipCoca-Cola: Top-Rated dividend stock breaks out ahead of earningsBP stock looks bullish on high dividend yield, new CEO3 high-quality dividend growers to buy on the dip More Dividend News This page (NASDAQ:CNCR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
